Menu
Search
|

Menu

Close
X

AbbVie Inc ABBV.N (New York Stock Exchange)

87.97 USD
-1.93 (-2.15%)
As of Oct 19
chart
Previous Close 89.90
Open 89.26
Volume 2,820,584
3m Avg Volume 1,545,224
Today’s High 89.99
Today’s Low 87.97
52 Week High 125.84
52 Week Low 85.30
Shares Outstanding (mil) 1,514.27
Market Capitalization (mil) 143,568.20
Forward P/E 22.12
Dividend (Yield %) 0.96 ( 4.05 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.45 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY18
16,212
FY17
28,216
FY16
25,638
FY15
22,859
EPS (USD)
FY18
2.991
FY17
3.547
FY16
3.641
FY15
3.133
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.12
32.14
Price to Sales (TTM)
vs sector
4.64
6.55
Price to Book (MRQ)
vs sector
--
4.00
Price to Cash Flow (TTM)
vs sector
16.87
21.51
Total Debt to Equity (MRQ)
vs sector
--
14.15
LT Debt to Equity (MRQ)
vs sector
--
11.31
Return on Investment (TTM)
vs sector
13.82
12.83
Return on Equity (TTM)
vs sector
517.77
14.95

EXECUTIVE LEADERSHIP

Richard Gonzalez
Chairman of the Board, Chief Executive Officer, Since 2013
Salary: $1,638,460.00
Bonus: $4,331,250.00
William Chase
Executive Vice President, Chief Financial Officer, Since 2013
Salary: $1,008,530.00
Bonus: $1,954,550.00
Michael Severino
Executive Vice President - Research & Development, Chief Scientific Officer, Since 2014
Salary: $1,004,460.00
Bonus: $1,955,070.00
Laura Schumacher
Executive Vice President, External Affairs, General Counsel and Corporate Secretary, Since 2013
Salary: $1,008,530.00
Bonus: $1,954,550.00
Carlos Alban
Executive Vice President - Commercial Operations, Since 2013
Salary: $947,469.00
Bonus: $1,836,220.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

1 N Waukegan Rd
NORTH CHICAGO   IL   60064-1802

Phone: +1847.9327900

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

SPONSORED STORIES